Olivier Bonny

Degrees  2009. Board certifications in Nephrology (FMH), Switzerland.  2007. Postdoctoral Certificate in Research, University of Texas, Southwestern Medical Center, Dallas, USA.  2005. Board certifications in Internal Medicine (FMH), Switzerland.  2002. MD-PhD, University of Lausanne, Switzerland. Thesis entitled \"Functional analysis of variants of the epithelial sodium channel\", under the supervision of Prof. B.C. Rossier.  1997. Certificates in molecular and cellular biology and in signaling and regulating pathways, University of Lausanne, Switzerland. MD-PhD program.  1993. Swiss Federal Diploma of Medicine, University of Lausanne, Switzerland. Clinical practice  02-2022 to date: Head, Service of Nephrology, State Hospital Fribourg, Fribourg, Switzerland.  02-2022 to date: Senior attending (Médecin agréé, 10%), Service of Nephrology, Lausanne University Hospital (CHUV), Switzerland; Clinic for renal genetic disorders.  2014 to 01-2022: Senior attending (Médecin Associé), Service of Nephrology, Lausanne University Hospital (CHUV), Switzerland; Prof. M. Burnier and F. Fakhouri.  12-2007 to 2014: Attending (Chef de clinique), Service of Nephrology, Lausanne University Hospital (CHUV), Switzerland; Prof. M. Burnier.  04-2002 to 06-2004: Fellow (Assistenzartz), Department of Nephrology and Hypertension, University Medical Center (Inselspital), Bern, Switzerland; Prof. F.J. Frey.  04-2000 to 03-2002: Fellow (médecin assistant) Department of Internal Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland; Prof. P. Nicod.  10-1994 to 09-1996: Resident in Internal Medicine and Surgery, St-Loup Hospital, Pompaples, Switzerland; Drs. Zwahlen, Breaud, Saillen, Schröder, de Roguin and Bachelin. Research / Academic path  02-2023 to date: Full clinical Professor, University of Fribourg, Fribourg, Switzerland  08-2017 to 01-2022: Associate Professor, Department of Pharmacology and Toxicology and of Medical Biosciences, University of Lausanne, Lausanne, Switzerland.  08-2016 to 07-2017: Deputy Professor (professeur remplaçant), Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.  08-2015 to 07-2016: Assistant Professor, Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.  08-2011 to 07-2015: Assistant Professor SNF, Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.  12-2007 to 07-2011: Junior group leader (Maitre-Assistant suppléant), Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.  07-2004 to 11-2007: Post-doctoral fellow, Center for Mineral Metabolism and Division of Nephrology, University of Texas, Southwestern Medical Center, Dallas, USA; Prof. O.W. Moe.  10-1996 to 03-2000: MD-PhD student, Department of Pharmacology and Toxicology, Lausanne, Switzerland; Prof. B.C. Rossier.  02-1994 to 10-1994: Student, Molecular Biology Laboratory, Department of Internal Medicine, University Medical Center, Lausanne, Switzerland; Prof. G. Waeber. Teaching  Medical school, University of Fribourg : ex-cathedra lectures and group-based teaching  Medical school, University of Lausanne: ex-cathedra lectures  CAS/DAS in renal physiology: instructor and lecturer in module 3 on mineral metabolism  Direction of Doctoral thesis (University of Lausanne):  Dusan Harmacek, MD student 2020-ongoing  Constance Legay, MD-PhD student (co-direction with Prof. M. Bochud). 2019-2022. Graduated.  Daniela Cabuzu, PhD student, 2018-2022. Graduated.  Yann Vuignier, MD, 2018-ongoing  Yimin Lu, PhD student, 2016-2020. Graduated.  David Granjon, PhD student (cotutelle with Paris UMPC), 2014-2016. Graduated.  Matthias Moor, MD-PhD student, 2013-2016. Graduated.  Anne Ruiz, PhD student, 2011-2016. Graduated.  Vlasta Zavadova, PhD student, 2010-2014. Graduated.  Direction of Master thesis (medical and life sciences students, University of Lausanne): list available upon request Competitive grants (last 5 years)  2018-2022. Swiss National Science Foundation. 310030_182312. 700’000 CHF.  2018-2022. NCCR “Kidney.CH”, third phase. Full participant, member of the steering committee and leader of the Swiss Kidney Stone Cohort  2016-2021. Swiss National Science Foundation, Investigator initiated trial 33IC30_166785. Randomized double-blind placebo-controlled trial assessing the efficacy of standard and low dose hydrochlorothiazide treatment in the prevention of recurrent calcium nephrolithiasis. Co-applicant (PI: Prof. D.G. Fuster). Total grant : 2'438'923 CHF. Awards  2017. Best publication award. Swiss Society of Nephrology.  2012. Among the seven best abstracts submitted (out of 2672), European Renal Association/ EDTA annual meeting, Paris  2007. Best oral presentation, Swiss Society of Nephrology, Annual meeting, Lausanne, Switzerland.  2001. Faculty Award, Lausanne Medical School, Switzerland. Societies  Swiss Society of Nephrology, General Secretary (2013-2018). President (2022-2023).  American Society of Nephrology, Member.  International Society of Nephrology, Member.  European Renal Association, Member  FMH/ASMAC, Member.  Swiss Working Group for Rare and Inherited Kidney Disease, Founding member, 2013  Swiss Kidney Stone Cohort, NCCR Kidney.CH, Founding member 2013. Leader since 2015  Swiss TSC Network, Founding member 2013 Academic activity  2023. Member, Commission of titularisation of Dr H. Chehade, UNI-Fribourg.  2022 to date. Member of the intramuros grant committee, HFR, Fribourg  2011-2017. Member of the MD-PhD committee of the Faculté de Biologie et Médecine, UNIL, Lausanne. Continuous Formation 2013-2022: Error reporting system (RECI). Responsible for the Service of Nephrology, CHUV. 2013: Media training course. Lausanne. 2017: Clinical Trial Investigator and sponsor, Swissethics certified. 2008-2009: Animal experimentation course. Module 1 and 2.